Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
P
046210
vs
K
KOSPI 200
Over the past 12 months, Panagene Inc has underperformed KOSPI 200, delivering a return of +8% compared to KOSPI 200's +108% growth.
Stocks Performance
046210 vs KOSPI 200
Performance Gap
046210 vs KOSPI 200
Performance By Year
046210 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Panagene Inc
Glance View
Panagene Inc. makes gene-analysis products based on peptide nucleic acid, or PNA, a synthetic DNA-like material that binds very tightly to genetic targets. The company sells research reagents, diagnostic components, and custom PNA products used to detect specific genes, mutations, and pathogens. In simple terms, it supplies the tools that help labs read and measure genetic information more precisely. Its main customers are hospitals, diagnostic labs, research institutes, and biotechnology companies that need reliable molecular testing ingredients. Panagene earns money by selling these products directly and through custom orders for specific tests or research projects. That makes its business tied to the life-science supply chain rather than to consumer sales. What sets Panagene apart is its focus on PNA, a niche chemistry used in specialized genetic testing. Instead of making broad medical devices or drugs, it sits upstream as a materials and assay supplier for people building or running DNA-based tests. That gives it a role as a technical ingredient provider in the genomics and diagnostics market.